Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (660)	1/24/1998 9:37:00 AM
From: Amigo Mike	Read Replies (1) \| Respond to of 1476

Gee ..... the board is real quiet. Well, at least there aren't people on here complaining the stock isn't $5 yet. Guess that's a good thing. Just to keep things going...... I do expect Antex to come out with a series of annuncements beginning last Wednesday though March. Announcements will likely be regarding info on 3 trial results, milestone money, earnings and year end financials, possibly something on the Blair situation and hopefully .... the start to a new trial for Moraxella and .... new licensing deal (possible). Mike

To: Amigo Mike who wrote (660)	2/18/1998 12:06:00 PM
From: John R Resseger	Respond to of 1476

Hi Antonions In the just released March issue of Consumer Reports, the scourge of Campylobacter, one of the diseases our Antex is testing a vaccine for, is presented. CR (Consumer Reports) bought around 1,000 chickens in 36 cities, over a 5-week period last fall. 63% had Campylobacter! CR says Public health officials guess 1.1 to 7M cases of foodborne infection in USA a year. Most victims recover in a week from fever and diarrhea. 20% suffer prolonged illness. Up to 10% get really sick, chronic arthritis, meningitis, and Guillain-Barre. Certain strains are resistant to antibiotics. Page 18 " Eventually, it may be possible to vaccinate chickens and or humans, against Campylobacter." Ironically the Headline of the CR issue is how to choose a mutual fund. most of which cant touch ANTX, at least today, because of the low stock price.